EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO TEVA 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO TEVA 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Commercialized
Register Number
81931
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Apr 4, 2017
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number81931
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (3)
EFAVIRENZActive
Quantity: 600 mg
Name: EFAVIRENZ
EMTRICITABINAActive
Quantity: 200 mg
Name: EMTRICITABINA
TENOFOVIR DISOPROXILO FOSFATOActive
Quantity: 291,22 mg
Name: TENOFOVIR DISOPROXILO FOSFATO
ATC CLASSIFICATION (3)
J05A
J05AR
J05AR06